RECURSION PHARMACEUTICALS, INC. (RXRX) Corporate Subsidiaries
RECURSION PHARMACEUTICALS, INC. (RXRX) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: RXRX
CIK: 1601830
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerMegan King
Audit LocationSeattle, Washington, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 424B5 | 2026-10-15 | — | 424B5 | 0001601830-26-000134 | View SEC Doc Filr Page |
| 8-K | 2026-10-15 | 2026-10-15 | 8-K | 0001601830-26-000128 | View SEC Doc Filr Page |
| 424B5 | 2026-10-15 | — | 424B5 | 0001601830-26-000126 | View SEC Doc Filr Page |
| 4 | 2026-10-07 | 2026-10-06 | FORM 4 | 0001601830-26-000120 | View SEC Doc Filr Page |
| 4 | 2026-10-07 | 2026-10-06 | FORM 4 | 0001601830-26-000119 | View SEC Doc Filr Page |
| 144 | 2026-10-06 | — | 144 Filing | 0001959173-26-007282 | View SEC Doc Filr Page |
| 144 | 2026-10-06 | — | 144 Filing | 0001959173-26-007281 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-10-01 | FORM 4 | 0001601830-26-000116 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-10-01 | FORM 4 | 0001601830-26-000115 | View SEC Doc Filr Page |
| 8-K | 2026-09-21 | 2026-09-15 | 8-K | 0001601830-26-000112 | View SEC Doc Filr Page |
| 4 | 2026-09-16 | 2026-09-15 | FORM 4 | 0001601830-26-000110 | View SEC Doc Filr Page |
| 4 | 2026-09-10 | 2026-09-08 | FORM 4 | 0001601830-26-000105 | View SEC Doc Filr Page |
| 144 | 2026-09-08 | — | 144 Filing | 0001628280-26-060859 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-09-01 | FORM 4 | 0001601830-26-000103 | View SEC Doc Filr Page |
| 144 | 2026-09-01 | — | 144 Filing | 0001959173-26-006610 | View SEC Doc Filr Page |
| 144 | 2026-08-21 | — | 144 Filing | 0001959173-26-006306 | View SEC Doc Filr Page |
| 144 | 2026-08-20 | — | 144 Filing | 0001959173-26-006256 | View SEC Doc Filr Page |
| 144 | 2026-08-19 | — | 144 Filing | 0001959173-26-006204 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-17 | FORM 4 | 0002020969-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-17 | FORM 4 | 0002006495-26-000012 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-17 | FORM 4 | 0001712276-26-000009 | View SEC Doc Filr Page |
| 144 | 2026-08-18 | — | 144 Filing | 0001959173-26-006192 | View SEC Doc Filr Page |
| 144 | 2026-08-13 | — | 144 Filing | 0001959173-26-005979 | View SEC Doc Filr Page |
| 144 | 2026-08-12 | — | 144 Filing | 0001959173-26-005928 | View SEC Doc Filr Page |
| 144 | 2026-08-10 | — | 144 Filing | 0001959173-26-005848 | View SEC Doc Filr Page |